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Abstract 
In the medical field, specialty polymers have great potential to meet the 
demands for bioabsorbable materials as base materials for new technologies. 
Targeted drug delivery, scaffolds for stem cell growth and intraoperative hemostasis 
are just a few of the many potential applications for these polymers. Bacterially 
derived polymers, which are known to be biocompatible, often contain harmful 
endotoxins. Removal of these endotoxins is necessary to create a safe biocompatible 
product that meets the FDA requirements on endotoxin limits for implants. This 
study examines the effectiveness of methanol and sodium hydroxide purification of 
Clear Coli™ developed by Lucigen and on LSBJ and RSCO2 strains of£. coli. The two 
purification methods, a non-solvent precipitation and a 0.2 M sodium hydroxide 
treatment method, were evaluated for their efficacy in removing endotoxin. Poly(3-
hydroxybutyrate) was produced in all three strains harboring the recombinant 
enzymes PhaCl(STQK), PhaA, and PhbB. Sodium hydroxide proved to be the most 
effective for method of removing endotoxins. After a single round of Na OH 
purification, 87% of endotoxins were removed from LSBJ and all detectable 
endotoxins were removed from RSCO2. It required three rounds of methanol 
purification to achieve a 77% reduction of en do toxin in LSBJ and removal of all 
detectable levels of endotoxin for RSCO2. Clear Coli was easiest to purify as one 
round of methanol purification removed 70% of LAL detected endotoxins from the 
polymer. 
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Introduction 
Specialty polymers are increasingly being utilized as biomedical materials for 
a wide variety of medical products. Some of these applications include targeted drug 
delivery, bioabsorbable scaffolds for stem cell growth of organs, and intraoperative 
hemostasis of osseous bleeding (Malafaya, Silva & Reis, 2007; Tiwari, Panthari, 
Katare & Kharkwal, 2014). Due to the incredible variety of applications for 
biopolymers, the physical properties must also be able to meet a variety of different 
requirements (lge, Umoru & Aribo, 2012). In general these polymers must at a 
minimum be bioabsorbable and biocompatible. Many naturally derived polymers 
are known to be biocompatible, however these materials can contain elements that 
produce an unfavorable immune response, thereby limiting the amount of material 
that can be used in a medical setting. 
Polyhydroxyalkanoates (PHAs) are polyesters that are generated from native 
and recombinant organisms (Lu, Tappe!, and Nomura, 2009). Non-native producers 
such as Escherichia coli are frequently chosen to produce such materials because of 
the relative ease with which this microorganism can be manipulated (Fidler, 1992). 
E. coli is a gram negative bacteria with an outer membrane that contains 
lipopolysaccharides (LPS). This LPS consists of three components; lipid A, a core 
oligosaccharide, and an 0-antigen polysaccharide (Wu et al, 2014). Lipid A, the 
hydrophobic anchor of lipopolysaccharide (LPS), consists of six acyl chains that are 
responsible for eliciting a powerful immune response in humans (Raetz & Whitfield, 
2002). Human response to endotoxins includes fever, disseminated intra-vascular 
coagulation, tissue necrosis, and septic shock. Human endotoxin studies have 
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shown that humoral response to endotoxins are approximately 250 times greater in 
humans than mice (Morrison & Ryan, 1987). An intravascular dose as little as 2-4 
ng/ml was found to be sufficient enough to elicit a systemic inflammatory response 
in one human study. (Calvano & Coyle, 2012). The FDA has set upper limits in 
respect to endotoxin levels. For medical devices, the limit is 0.5 EU/ml or 20 EU per 
device for products that directly or indirectly contact the cardiovascular or 
lymphatic system (U.S. Department of Health & Human Services Food and Drug 
Administration, 2012). 
Removal of endotoxins from polymers is not a novel idea. Considerable 
research has been performed to assess the most efficient way of removing 
endotoxins from polymers that, at the same time, does not significantly diminish 
yield, reduce purity, or compromise PHA integrity. Current methods for endotoxin 
removal from polymers include temperature-controlled extraction and 
precipitation, purification using activated charcoal, and sodium hydroxide digest 
(Furrer, Panke & Zinn, 2007; Wampfler et al, 2010; Lee et al, 1999). 
The first goal of this study was to determine the endotoxin levels of crude 
PHAs procured from E.coli strains RSCO2 and LSBJ. The second goal of this study 
was to test the hypothesis that both methanol purification and sodium hydroxide 
purification are effective means of removing residual endotoxin from E. coli strains 
RSCO2 and LSBJ. The third goal of this study was to assess the endotoxin level of 
non-purified PHAs produced from Clear CoW": transformed with the same plasmid 
as the aforementioned strains. 
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Materials and Methods 
Two separate experiments were performed to assess distinct aspects of 
endotoxin levels. For Experiment 1, all reagents were made using endotoxin free 
water and in glassware that was endotoxin free. This was performed to assess 
relative endotoxin levels of bacterial strains post growth and to evaluate endotoxin 
levels after a single methanol purification. For Experiment 2, no endotoxin 
precautions were made with the exception of the materials and glassware 
associated with the steps directly prior to endotoxin assays. Water used for growth 
cultures in the production of PHAs was ultra-filtered water (NANOpure), which was 
also tested for residual endotoxins in this study. This second experiment was 
performed to simply evaluate the change in endotoxin levels after being subjected to 
repeated methanol purification as well as a sodium hydroxide purification. Three 
bacterial strains were chosen as the designated gram-negative species to be studied 
and are listed in Table 1. ln all strains the plasmid pBBR-STQKAB was used to 
transform the bacteria (Table 1). Kanamycin was added at a concentration of 50 mg 
L- 1 for plasmid selection and retention whenever appropriate. 
Preparation of glassware 
All glassware used in endotoxin free production of PHA's and in the 
preparation of the endotoxin assays were either endotoxin free from the 
manufacturer or made endotoxin free through heat destruction. Heat destruction of 
endotoxins was accomplished by baking glassware at 240°C for 1 hour. In order to 
allocate samples for testing, portions of the polymers were cut using surgical grade 
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Mayo scissors and surgical grade Kelly clamp hemostats. These instruments were 
flame sterilized by propane torch until red-hot and immediately cooled using 
endotoxin free water and allowed to dry. This practice was used to expedite the 
sampling process, and was performed for every individual sample prepared for 
endotoxin testing. 
PHA production in Clear Coli™ 
Clear Coli™ purchased from Lucigen was used as a control strain for 
endotoxin. This genetically modified E. coli strain has a deletion of two of the six acyl 
chains in lipid IVA and is reported to not induce an endotoxin response in mammals. 
Electrocompetent Clear Co WM cells were transformed with 3 µl of pBBRSTQKAB 
using electroporation (1500V, 5ms; BTX ECM 399). Transformed cells were then 
used to inoculate 500 µI of LB and recovered at 37°C for one hour with 200 rpm 
rota ry shaking. A 250 µl aliquot of recovered cells were then plated onto endotoxin 
free LB Miller plates (10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 sodium chloride, 
15 g L-1 agar) with kanamycin (50 mg L-1 ) and grown for 24 hours at 37°C. Three 
colonies were chosen and used to inoculate a growth medium of 50ml LB Miller 
with kanamycin. This seed culture was then grown for 36 hours at 37°C incubation 
with 200rpm rotary shaking. A 2 ml aliquot of seed culture was used to inoculate a 
growth medium of 100 ml LB Miller with kanamycin in baffled shake flasks. Cell 
cultures were grown for 96 hours at 30°C with 250rpm rotary shaking. 
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PHA production in LSBJ and RSC02 
Chemically competent LSBJ and RSCO2 E. Coli cells were transformed with 3 
µl of plasmid using a 1 minute of 42°C heat shock following standard procedures 
(Sambrook & Russell, 2001). Transformants were cooled for 2 minutes on ice and 
then used to inoculate 500 µl of LB and allowed to recover at 37°C for one hour with 
200 rpm rotary shaking. A 250 µl aliquot of recovered cells were then plated onto 
endotoxin free LB Miller plates with kanamycin and grown for 16 hours at 37°C. 
Three colonies were chosen and used to inoculate a growth medium of 50 ml LB 
Miller with kanamycin. This seed culture was then grown for 16 hours at 37°C 
incubation with 200 rpm rotary shaking. A 2ml aliquot of seed culture was used to 
inoculate a growth medium of 100 ml LB Miller with kanamycin in baffled shake 
flasks. Cell cultures were grown for 48 hours at 30°C with 250 rpm rotary shaking. 
Harvest of cells 
Following the growth period of all strains, cells were harvested in 
preparation for polymer extraction. Combined cell culture was divided into two 
separate 400ml containers and centrifuged at 4000g for 45 minutes at room 
temperature to pellet the cells. Supernatant was poured off and the cells washed 
with 40ml water of approximately 35% ethanol mix with vortexing. Once cells were 
fully reconstituted, they were distributed equally among four 50 ml Falcon tubes 
and were pelleted again for 30 minutes with the same centrifuge parameters as 
above and then supernatant decanted. Cells were then washed with 20ml water 
with vortexing, and pelleted again for 20 minutes. The supernatant was decanted, 
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cells reconstituted with 4 ml of water, and then stored at -80°C. After the freezing 
overnight, the cells were lyophilized for a minimum of 24 hours in preparation for 
polymer extraction. 
Extraction and purification of PHAs 
Freeze dried cells were extracted by soxhlet using chloroform for a minimum 
of 5 hours. Following extraction, chloroform was concentrated using rotary 
evaporation until a solid polymer film was visualized. Polymer was then placed on a 
high vacuum unit for a minimum of 2 hours to remove any residual chloroform. A 
crude sample was then aseptically excised and set aside using endotoxin-free tools. 
Once a crude sample had been set aside, remaining polymer was brought 
back into solution with 20 ml of chloroform with heating (55°C). The solution was 
then cooled and added dropwise by pipette into 150ml of ice cold methanol solution 
( ~4°C) with moderate stirring. The precipitated sample was then transferred to a 
scintillation vial and placed under high vacuum to remove all chloroform. A small 
portion was aseptically excised and retained as the first methanol purification 
sample. The remaining polymer was then subjected to two additional rounds of 
methanol purification as described above. 
Sodium hydroxide purification of PHAs 
To perform the sodium hydroxide digest at the conclusion of the final 
centrifuge step during cell harvest, the supernatant was decanted, and the pellet 
was then instead reconstituted with 20 ml of 0.2 M Na OH with vortexing. Centrifuge 
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tubes (50ml) were then placed on their side and incubated at 37°C with 100 rpm 
transverse shaking for 5 hours. The solution in each tube was then neutralized with 
1 M HCL and centrifuged at 2500g for 20 minutes. Supernatant was decanted and 
the cells reconstituted with 4ml of endotoxin free water, then placed in a -80°C 
freezer for storage. After the freezing overnight, cells were placed on a lyophilizer 
for a minimum of 24 hours in preparation for polymer extraction. 
Endotoxin assay 
Assessment of endotoxin levels in polymer samples was accomplished using 
the Pierce™ Limulus Amebocyte Lysate Chromogenic Endotoxin Quantitation Kit. 
Polymer samples were prepared for testing following a previously described 
protocol, with adaptation (Furrer, Panke, & Zinn, 2007). Briefly, polymer samples 
were prepared by aseptically transferring approximately 200 mg of weighed sample 
into endotoxin free glass vials. A 4ml aliquot of endotoxin free water was added to 
samples. Sample vials were then incubated at 37°C with 200 rpm rotary shaking for 
24 hours. For samples that were tested for endotoxin leeching over time, water 
within the sample vials was changed at the 24 hour mark and placed back into the 
rotary incubator for an additional 24 hours. Both 24 hour and 48 hour water 
samples were tested for endotoxin levels. Endotoxin assays were carried out 
following the manufacturer's recommendations. The spectrometer used for this 
study was a Biotek Synergy H4 microplate reader. 
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Results 
Endotoxin levels in strains experiment 1 
The Clear CoWM strain showed the highest endotoxin value by LAL assay 
(Table 2, Figure 1). Reduction of endotoxin values was also the greatest for this 
strain post methanol purification. The strain RSCO2 showed 22% more endotoxin 
than did LSBJ, however it showed only a 41 % reduction after a single round of 
methanol purification compared to a 50% endotoxin reduction for LSBJ. 
Endotoxin reduction in strains experiment 2 
Similar to experiment 1, one round of methanol purification removed 5% 
more endotoxin from LSBJ than RSCO2 (Table 3, Figure 2). A second round of 
methanol purification removed an even greater degree of endotoxin for LSBJ 
relative to RSCO2 on the order of 19%. Subsequent methanol purification however 
showed a greater degree of endotoxin removal for RSCO2 than LSBJ. A third 
purification removed all detectable levels of endotoxin in RSCO2, whereas the LSBJ 
strain endotoxin levels were reduced by only ~78% overall. The final purification 
step was largely ineffective at removing endotoxins from LSBJ with a reduction 
percentage of only 3.6%. The sodium hydroxide purification of RSCO2 reduced the 
endotoxin to undetectable levels by assay after one treatment (Table 4). The 
endotoxin was reduced by ~87% for the LSBJ strain. 
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Endotoxin leech over time 
The water sample taken at the 48-hour mark for Clear Coli™ was shown to 
contain roughly 83% less endotoxin than the 24-hour mark (Table 5). The water 
samples for both the 24-hour and 48-hour marks for the RSC02 strain was shown to 
be identical by assay. 
Discussion 
The high endotoxin values for the crude Clear Coli™ showed that the LAL 
assay was unable to distinguish between the 4-acyl chain variant and the standard 
6-acyl chain endotoxins. According to Lucigen, a false-positive endotoxin value is 
produced from the interaction of the 4'-monophosphoryldiglucosamine backbone of 
LPS with the LAL reagent. Standard practice to reduce false positives of this strain is 
to run samples through a nickel column purification step before LAL testing. 
Unfortunately, this practice cannot be applied as easily to polymers as it can with 
general recombinant proteins. Methanol purification was significantly more 
effective at removing LPS from the Clear Colin,, strain than either LSBJ or RSC02. 
This suggests that the genetically modified LPS molecules are much more loosely 
attached to the polymer than the unaltered LPS of LSBJ and RSC02. 
Values for the crude samples for Experiment 2 were reported as "overflow" 
because the concentration of endotoxin was beyond the upper limit of the 
spectrometer unit's ability to report them. A likely cause was that the additional 
endotoxin introduced as a result of not using endotoxin free water was enough to 
bring the concentration above the maximum threshold. Taking this into 
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consideration, endotoxin reduction values for Tables 3 and 4 were calculated using 
the least possible crude concentration. This represents the minimum endotoxin 
concentration at which the spectrometer reports an overflow value. 
A single round of methanol purification produced similar endotoxin 
reductjon percentages in both experiment 1 and 2, with LSBJ averaging more 
endotoxin reduction than RSC02. A subsequent methanol purification for both 
strains yielded an endotoxin reduction percentage slightly higher than the first 
purification. However, the strain RSC02 displayed the greatest reduction upon the 
third methanol purification, whereas the LSBJ strain was largely unaffected by the 
final purification. This resulted in virtually all of the endotoxin having been removed 
from RSC02 while approximately 12% of the original endotoxins remained for the 
strain LSBJ. A possible explanation for the large discrepancy in the effectiveness of 
the final methanol purification between the two strains may very well be attributed 
to the technique itself. It was critical during the purification that the dissolved 
polymer be added slowly and dropwise into stirring methanol. Any addition of 
polymer that was added faster than a dropwise rate could very well have escaped 
the full effectiveness of the purification. Nevertheless, it was apparent that a 
minimum of three rounds of purification was necessary to achieve elimination of 
nearly all endotoxin. 
Sodium hydroxide purification proved to be the most effective way to 
remove endotoxins from both strains. After a single purification step, virtually all 
detectable levels of endotoxin was removed from the RSC02 strain, while LSBJ 
attained greater than a 87% reduction in endotoxin levels. 
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Assessment of endotoxin levels after a water exchange for Clear Coli™ 
showed a significant 83% concentration reduction, while the RSC02 levels remained 
identical. It is likely that the altered endotoxin in Clear CoWM is not strongly retained 
in the polymer, and can be removed by water rinses. Endotoxins appear to remain 
strongly attached to the polymer produced by the RSC02 strain. The fact that the 
endotoxin levels remained identical after a water exchange suggests that there is an 
endotoxin equilibrium that is attained with incubation over a 24 hour period. 
Subsequent water exchanges would have little effect on endotoxin levels for the 
RSC02 strain. 
Conclusion 
Sodium hydroxide purification was found to be far more effective at 
removing endotoxins from RSC02 and LSBJ than methanol purification. A single 
round of sodium hydroxide was, at very minimum, equivalent to three rounds of 
methanol purification. Clear Coli was able to be further purified with a water rinse, 
whereas the RSC02 strain showed no endotoxin changes after a water exchange. 
This suggests that the normal 6-acyl chain LPS of gram-negative bacteria is strongly 
attached to the polymer produced by them. The altered 4-acyl chain 
lipopolysaccharides produced by Clear Coli were significantly reduced by the water 
rinse, suggesting that the altered LPS is only loosely attached to the polymer. 
Interestingly, a single water rinse was shown to remove more endotoxin from the 
polymer produced by Clear Coli than a round of methanol purification. Further 
studies need to be performed to assess whether water alone can purify Clear Coli 
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produced polymer below the detection limit for the LAL endotoxin assay. Further 
studies also need to be performed to assess whether or not the sodium hydroxide 
caused any molecular changes to the polymer. While it is possible to either 
significantly reduce or remove all detectable endotoxin from LSBJ and RSC02 
strains using methanol purification, this study showed that sodium hydroxide is a 
far more efficient procedure that both reduces cost and waste material. 
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Tables 
Table 1: Strains and Plasmid 
Strain/Plasmid Relevant characteristics 
Strains 
Clear Coli™ 
E. coli LSBJ 
E. coli RSC02 
Plasmid 
pBBRSTQKAB 
.1gutQ .1kdsD .1lpxL .1lpxM .1pagP .1lpxP .1eptA 
msbA148 
E. coli LS5218 JadB::Cm, !J.fadj 
E. coli LSB] LlarcA 
pBBRlMCS-2 derivative, phaCl (STQK), phbAB 
All strains and plasmid used during this study. 
Source or 
reference 
1 
2 
3 
4 
1) Clear Coli Expression Technology, 2016; 2) Tappe!, Wang & Nomura, 2012; 
3) Manuscript in preparation 4) Nomura et al, 2004. 
Table 2: Endotoxin Levels of Strains 
Strains Crude Methanol Purified 
EU/mg EU/mg 
Clear Coli™ 0.160 0.049 
RSCO2 0.136 0.080 
LSBJ 0.106 0.053 
Percent Change 
69.5% 
41.2% 
49.8% 
Values were calculated as the average of quadruplicate experiments. 
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Table 3: Percent Reduction of Endotoxin From Methanol Purification 
Percent endotoxin reduction per round of purification 
Strains First Purification Second Purification Third Purification 
RSCO2 >37.4% 40.9% 
LSBJ >42.3% 59.8% 
Cumulative endotoxin level reduction percentage 
99.9% 
3.57% 
Strains First Purification Second Purification Third Purification 
RSCO2 >37.3% >62.9% >99.9% 
LSBJ >42.3% >76.8% >77.7% 
Percent reduction was calculated using endotoxin values corresponding to the 
maximum detection limit of the spectrometer. 
Values were calculated as the average of quadruplicate experiments. 
Table 4: Percent Reduction of Endotoxin From Sodium Hydroxide Purification 
Strains Crude Purified Percent Reduction 
EU/mg EU/mg 
RSCO2 >0.021 Below detection >99.9% 
limit 
LSBJ >0.021 0.0028 >87.1% 
Percent reduction was calculated using endotoxin values corresponding to the 
maximum detection limit of the spectrometer. 
Values were calculated as the average of quadruplicate experiments. 
Strains 
Clear Coli™ 
RSCO2 
Table 5: Endotoxin Values Post Water Exchange 
24 Hour Endotoxin 
Value EU/mg 
0.0139 
0.0135 
48 Hour Endotoxin Percent Change 
Value EU/mg 
0.0024 82.6% 
0.0135 0% 
Values were calculated as the average of quadruplicate experiments. 
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Table 6: Endotoxin Values of Water Reagents 
Reagent Endotoxin EU /ml 
Endotoxin Free Water 
Distilled Water 
Nanopure Water 
0 
0 
0.695 
Values were calculated as the average of quadruplicate experiments. 
0.180 1 
0.160 1 
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Purified 
Figure 1: Endotoxin Levels of PHBs Pre and Post Methanol 
Purification. Clear Coli showed the greatest percent reduction of 
endotoxin at 70%, while LSBJ endotoxin percent reduction was 41 % 
and RSCO2 reduction was shown as 50% after one round of methanol 
purification. RSCO2 retained the greatest amount of endotoxin post 
methanol purification. Values were calculated as the average of 
quadruplicate experiments. 
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Figure 2: Endo toxin Values of methanol purified RSC02 and LSBJ at 
each purification step are shown above. The RSC02 strain showed no 
detectable endotoxin after the third purification while the LSBJ strain 
showed no further endotoxin removal after the second methanol 
purification step. Values were calculated as the average of 
quadruplicate experiments. 
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